Category:FDA approved in 2021

From HemOnc.org - A Hematology Oncology Wiki

Jump to: navigation, search

Drugs with initial FDA approval in 2021.

Pages in category "FDA approved in 2021"

The following 12 pages are in this category, out of 12 total.

A

B

Belumosudil (Rezurock)

D

Dostarlimab (Jemperli)

I

L

M

Melphalan flufenamide (Pepaxto)

S

Sotorasib (Lumakras)

T

Tepotinib (Tepmetko)

U

Umbralisib (Ukoniq)

Retrieved from "https://hemonc.org/w/index.php?title=Category:FDA_approved_in_2021&oldid=47066"

FDA approved in the 2020s